Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
23.12.24
/
50%
€379.25
Target price
23.12.25
€480.45
Performance (%)
-12.66%
Price
06.08.25
€331.25
Summary
This prediction is currently active. The prediction for Vertex Pharmaceuticals Inc. disappoints with a performance of -12.66%. This prediction currently runs until 23.12.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -19.365% | -19.365% |
| iShares Core DAX® | -0.933% | 0.936% |
| iShares Nasdaq 100 | -2.152% | 3.580% |
| iShares Nikkei 225® | 0.021% | 1.387% |
| iShares S&P 500 | -2.296% | 2.847% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $503.00 to $500.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€404.90
14.07.25
14.07.25
€442.35
14.07.26
14.07.26
-18.19%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€387.85
06.05.25
06.05.25
€455.98
06.05.26
06.05.26
-14.59%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€457.60
05.11.24
05.11.24
€460.55
05.11.25
05.11.25
-27.61%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€432.30
05.08.24
05.08.24
€464.36
05.08.25
05.08.25
-24.98%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€400.30
01.02.24
01.02.24
€404.41
01.02.25
01.02.25
10.22%
02.02.25
02.02.25